Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India.
Decreased susceptibility of Neisseria meningitidis isolates to ciprofloxacin emerged from an outbreak in Delhi, India. Results of antimicrobial susceptibility testing of the meningococcal isolates to ciprofloxacin and further sequencing of DNA gyrase A quinolone-resistance-determining region confirmed the emergence of ciprofloxacin resistance in the outbreak.
Singhal
Smita
S
Ranbaxy Research Laboratories, Gurgaon, India.
Purnapatre
Kedar P
KP
Kalia
Vandana
V
Dube
Smita
S
Nair
Deepti
D
Deb
Monorama
M
Aggarwal
Pushpa
P
Gupta
Sunil
S
Upadhyay
Dilip J
DJ
Rattan
Ashok
A
Raj
V Samuel
VS
D002939:Ciprofloxacin / Q000494:pharmacology; D004196:Disease Outbreaks; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D007194:India / Q000453:epidemiology; D008589:Meningococcal Infections / Q000188:drug therapy / Q000453:epidemiology*; D008826:Microbial Sensitivity Tests; D038381:Neisseria meningitidis, Serogroup A / Q000145:classification / Q000187:drug effects* / Q000235:genetics; D012703:Serotyping
D002939:Ciprofloxacin